Completed OBSERVATIONAL NCT00011258

Paraoxonase and LDL Oxidation in Carotid Artery Disease

Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Interventions Paraoxonase

Updated 7 times since 2017 Last updated: Jan 20, 2009 Started: Mar 31, 1997 Completion: Sep 30, 2003

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00011258, this observational or N/A phase trial focuses on Carotid Stenosis and remains completed. Sponsored by National Heart, Lung, and Blood Institute (NHLBI), it has been updated 7 times since 1997, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Aug 2018 — Jan 2021 [monthly]

Completed
Jun 2018 — Aug 2018 [monthly]

Completed

▶ Show 2 earlier versions

Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Completed NA

First recorded

Mar 1997

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Heart, Lung, and Blood Institute (NHLBI)
US Department of Veterans Affairs

Data source: VA Office of Research and Development

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Seattle, United States